logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Frontiers in Pharmacology cover

Frontiers in Pharmacology

IF4.8
Papers6301
Citations105995
Journal Papers 5804
Publication Date
delete
Targeting the Correa’s cascade of gastric cancer: the potential role of phytochemicals and autophagy modulation
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteTW Tingyao Wang †; FY Fuming Yao †; RL Ruilin Li; JZ Jijun Zheng; HZ Hebin Zhang; JM Jia Ma; YW Yueqiang Wen; XM Xiao Ma; JZ Jinhao Zeng
deleteShare
deleteSave
Traditional Chinese botanical medicines and plant-derived bioactive compounds in amyotrophic lateral sclerosis: mechanistic evidence, translational challenges, and therapeutic opportunities
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteML Mengfan Li; RL Ronghao Li; ZD Zhe Deng; LZ Liqun Zhang; SL Shimeng Lv; JS Jinjing Shi; HM Haoteng Ma; WG Wenhui Guan; HZ Han Zhang; JL Jiamin Li; JT Jing Teng
deleteShare
deleteSave
Tirzepatide versus other anti-diabetic agents for the prevention of diabetic foot complications in patients with type 2 diabetes
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteCK Chia-Yu Kuo; JW Jheng-Yan Wu; YT Ya-Wen Tsai; CL Chih-Cheng Lai; JW Jiun-Ling Wang
deleteShare
deleteSave
Targeting lysosomal ion channels to overcome cancer treatment resistance: emerging mechanisms and therapeutic opportunities
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteNL Na Luo †; QW Qiuxiang Wang †; JZ Jun Zhang; ZD Zhiqin Deng
deleteShare
deleteSave
N-salicyloyl tryptamine derivatives as potential therapeutic agents for doxorubicin-induced hepatotoxicity via PI3K/AKT/HO-1 signaling pathway
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteYZ Yuting Zhao †; JZ Jing Zeng †; GP Guanglong Pang †; YW Ying Wu; SW Shuzhi Wang; ZL Zhengwen Lei; XH Xiangyong Hao; YC Yaxin Chen; CH Chengxuan Hu; XZ Xianlin Zeng; XH Xinyan Huang; XZ Xinlin Zhong; ZW Zhen Wang; XP Xue Peng
deleteShare
deleteSave
Hepatoprotective action of Dendrobium officinale polysaccharide against MAFLD: modulation of gut microbiota-metabolite cascade controls TLR4/NF-κB inflammatory response
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteYX Yumei Xu †; YZ Yanmei Zhang †; SL Shuqing Li †; HY Heyan Yao; YY Yang Yang; CY Cuiping Yu; SZ Shunzhen Zhang
deleteShare
deleteSave
Correction: Proton pump inhibitor prescription patterns in hospitalized patients before and after targeted intervention
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteJG Johny Gerjy Salem; SJ Sarah Jalloul; AH Ahmad Hammoud; JA Jihane Atrash; KH Karim Halabi; MA Melissa Alkatrib; MS Mira Sabat; LC Louis Chaptini
deleteShare
deleteSave
High-affinity ELR+ CXC chemokines display balanced G protein-, GRK- and β-arrestin-associated transducer engagement at the viral G protein-coupled receptor ORF74
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteQK Qianqian Kong; BV Brent Van Bosstraeten; SD Steven De Jonghe; DS Dominique Schols; TV Tom Van Loy
deleteShare
deleteSave
Targeting the AcrAB-TolC efflux pump by small molecules selectively addressing the outer membrane factor TolC
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteJV Janis Veliks †; CD Cristina D. Cruz †; TS Tania Szal †; MM Marina Madre; IL Irena Leite; LP Laura Paunina; PL Philipp Lewe; MH Maren Hinz; SW Susanne Witt; PT Päivi Tammela; AJ Aigars Jirgensons; BW Björn Windshügel
deleteShare
deleteSave
Omalizumab for pediatric allergic asthma: evidence-based insights on efficacy and safety from a meta-analysis of randomized trials
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteJH Jinbiao Han; ZZ Zhuan Zou; SW Shanshan Wu; BC Bin Chen
deleteShare
deleteSave
Cannabinoids in hematologic malignancies: mechanisms and therapeutic potential for overcoming drug resistance
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteSL Sixu Li †; XJ Xiaokun Jian †; YT Yufu Tang; ZW Zhentao Wang; TM Tianjiao Min; LY Luyao Yu; BJ Beier Jiang; YH Ying He
deleteShare
deleteSave
Resistance mechanisms and reversal strategies of PD-1/PD-L1 inhibitors in melanoma
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteYL Yuhua Li †; JW Jing Wu †; WL Weiming Liao †; CW Chunyan Wang
deleteShare
deleteSave
Incidence, burden, and associated factors of severe potential drug–drug interactions in intensive care unit patients: a real-world retrospective study
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteHJ Huaqiao Jiang; TS Tingting Shen; YY Yun Yang; LZ Lin Zhang; XT Xiaofang Tan; XL Xiaoqun Lv; YL Yanhua Lin †; NZ Ning Zhang †
deleteShare
deleteSave
Efficacy and safety of Compound Danshen Dripping Pills as an adjunct to conventional therapy for stable angina pectoris: an updated systematic review and meta-analysis of randomized controlled trials
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteXZ Xiaoyue Zhao †; YL Yaoyuan Liu †; LY Liying Yang; ZC Zeqi Chen; WZ Wenjun Zhang; WL Weijing Lu; YZ Yingda Zhao; ZZ Zhicheng Zhou; FY Fengwen Yang; WP Wentai Pang
deleteShare
deleteSave
Toxicoproteomics of APAP-exposed HepG2 cells identifies candidate translational biomarkers of liver injury and recovery
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteAS Ana S. Serras; SP Sérgio P. Camões; RV Rui Vitorino; JP Joana P. Miranda
deleteShare
deleteSave
Astragaloside IV in hepatocellular carcinoma: repolarizing macrophages to reprogram the tumor microenvironment
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deletePM Peng Ma †; XL Xin-da Lu †; JH Jian-li Han; JD Jia-jia Du
deleteShare
deleteSave
Integrated network toxicology and multi-omics profiling reveal cell cycle, DNA damage repair, and metabolic alterations in cyclophosphamide-induced premature ovarian insufficiency
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteZY Zhaoyang Yu †; LL Lidan Liu †; XZ Xiqian Zhang; YL Ying Li; YN Yingqi Nong; LK Lingyu Ke; ML Mujun Li; YW Yuxia Wang; HW Huimei Wu; FL Fenghua Liu
deleteShare
deleteSave
Ciprofol versus propofol for painless gastrointestinal endoscopy: a dose-stratified systematic review and meta-analysis
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteJL Jing Liu †; JY Jun Yu †; ZC Zhiyong Chen; YB Yuchao Bai; XZ Ximeng Zhang; JD Jian Du
deleteShare
deleteSave
Targeting the PCSK9–PR–IL-17 axis for psoriasis therapy
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteYL Yan Li †; YH Yingxue He †; SH Shengwei He; ZY Zirun Yin; KH Kai Huang; CJ Chenyang Jiao; YX Yugui Xia; QL Qiong Luo; CL Chao Luan; WG Wenjie Guo
deleteShare
deleteSave
Natural metabolites targeting macrophage polarization for non-small cell lung cancer therapy: a review of mechanisms and applications based on chemical classification
deleteFrontiers in Pharmacology
IF4.8
delete2026-09-27
delete0
deleteOAAI
deleteYZ Yuxuan Zhang †; LL Lu Liu †; XD Xiaoyan Dai; HY Hongyan Yan; XL Xudong Lei; HY Hua Yang
deleteShare
deleteSave